Quick test finds signs of sepsis in a single drop of blood
A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood.
A team of researchers from the University of Illinois and Carle Foundation Hospital in Urbana, Illinois, completed a clinical study of the device, which is the first to provide rapid, point-of-care measurement of the immune system’s response, without any need to process the blood.
This can help doctors identify sepsis at its onset, monitor infected patients and could even point to a prognosis, said research team leader Rashid Bashir, a professor of bioengineering at the U. of I. and the interim vice dean of the Carle Illinois College of Medicine. The researchers published their findings in the journal Nature Communications.
Sepsis is triggered by an infection in the body. The body’s immune system releases chemicals that fight the infection, but also cause widespread inflammation that can rapidly lead to organ failure and death.
Sepsis strikes roughly 20 percent of patients admitted to hospital intensive care units, yet it is difficult to predict the inflammatory response in time to prevent organ failure, said Dr. Karen White, an intensive care physician at Carle Foundation Hospital. White led the clinical side of the study.
“Sepsis is one of the most serious, life-threatening problems in the ICU. It can become deadly quickly, so a bedside test that can monitor patient’s inflammatory status in real time would help us treat it sooner with better accuracy,” White said.
Sepsis is routinely detected by monitoring patients’ vital signs – blood pressure, oxygen levels, temperature and others. If a patient shows signs of being septic, the doctors try to identify the source of the infection with blood cultures and other tests that can take days – time the patient may not have.
The new device takes a different approach.
“We are looking at the immune response, rather than focusing on identifying the source of the infection,” Bashir said. “One person’s immune system might respond differently from somebody else’s to the same infection. In some cases, the immune system will respond before the infection is detectable. This test can complement bacterial detection and identification. We think we need both approaches: detect the pathogen, but also monitor the immune response.”
The small, lab-on-a-chip device counts white blood cells in total as well as specific white blood cells called neutrophils, and measures a protein marker called CD64 on the surface of neutrophils. The levels of CD64 surge as the patient’s immune response increases.
The researchers tested the device with blood samples from Carle patients in the ICU and emergency room. When a physician suspected infection and ordered a blood test, a small drop of the blood drawn was given to the researchers, stripped of identifying information to preserve patient confidentiality. The team was able to monitor CD64 levels over time, correlating them with the patient’s vital signs. Researchers found that the results from the rapid test correlated well with the results from the traditional tests and with the patients’ vital signs.
“By measuring the CD64 and the white cell counts, we were able to correlate the diagnosis and progress of the patient – whether they were improving or not,” said Umer Hassan, a postdoctoral researcher at Illinois and the first author of the study. “We hope that this technology will be able to not only diagnose the patient but also provide a prognosis. We have more work to do on that.”
Bashir’s team is working to incorporate measurements for other inflammation markers into the rapid-testing device to give a more complete picture of the body’s response, and to enable earlier detection. They also have a startup company, Prenosis Inc., that is working to commercialize the device.
“We want to move the diagnosis point backward in time,” Bashir said. “The big challenge in sepsis is that no one knows when you get infected. Usually you go to the hospital when you already feel sick. So the goal is that someday you can be testing this at home, to detect infection even earlier if you can.”
The Latest on: Sepsis
- Identifying neonatal early-onset sepsis test and treatment decision thresholdson March 1, 2021 at 6:40 am
To derive testing and treatment thresholds for early-onset neonatal sepsis and compare them to thresholds used in the Kaiser-Permanente (KP) Sepsis Calculator. Methods.
- Blocking Msr1 by berberine alkaloids inhibits caspase-11-dependent coagulation in bacterial sepsison February 27, 2021 at 4:00 pm
Msr1 is a scavenger receptor (SR) facilitating endocytosis of modified low-density lipoprotein and pathogens. We revealed a novel role of Msr1 that mediates endocytosis of LPS and consequently ...
- Sepsis Diagnostics Market Size, Share and Analysis to Cross US $1,033.02 Mn by 2026 - Industry Growthon February 25, 2021 at 4:05 am
Worldwide sepsis diagnostics market is estimated to amass around US $1,033.02 million by the year 2026, according ...
- Vitamin C Fails Again As Treatment For Sepsison February 24, 2021 at 1:40 pm
Sepsis is one of the most common causes of death for hospitalized patients. The search for an effective treatment has been frustrating.
- Vitamins and steroid combination in sepsis patients do not improve recovery, organ failure or death in clinical trialon February 24, 2021 at 7:00 am
A Phase III clinical trial at Emory University and 42 other U.S. sites has determined that a vitamin and steroid combination given to critically ill patients with sepsis did not improve recovery, ...
- Sepsis costs Ontario health care system $1 billion a year: studyon February 23, 2021 at 1:19 pm
A new Ottawa-led study shows that sepsis costs the provincial health care system $1 billion a year, underlining the importance of early identification and treatment of the life-threatening condition.
- Sepsis Diagnostics Market 2021 : Market Size, Growth, Top Countries Data with Overview and Geographical Forecast Till 2026on February 23, 2021 at 1:19 am
According to 360 Research Reports, the “Sepsis Diagnostics Market" 2021 by Types (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), Application (Laboratory Testing, Point-of-care ...
- Detecting multiple sepsis biomarkers from whole blood—made fast, accurate, and cheapon February 12, 2021 at 9:17 am
Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment.
- Virtual post-sepsis recovery program may also help recovering COVID-19 patientson February 10, 2021 at 8:10 am
In "Translating Post-Sepsis Care to Post-COVID Care: The Case for a Virtual Recovery Program," Stephanie Parks Taylor, MD, Department of Internal Medicine, Atrium Health, Charlotte, North Carolina ...
- Virtual recovery program for sepsis patients may also help in post-COVID careon February 9, 2021 at 4:01 pm
This multicomponent sepsis transition and recovery program, known as "STAR," is conducted virtually by a specialized nurse navigator, who provides best-practice care for high-risk sepsis survivors ...
via Google News and Bing News